Telo Genomics Corp.
TDSGF
$0.0882
$0.020630.47%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -1.91M | -2.00M | -2.20M | -2.28M |
| Total Depreciation and Amortization | 20.00K | 25.50K | 29.20K | 30.40K | 29.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -35.40K | 10.40K | 41.80K | 100.80K | 139.60K |
| Change in Net Operating Assets | 314.00K | 226.00K | 115.20K | 121.70K | 99.60K |
| Cash from Operations | -1.43M | -1.64M | -1.82M | -1.95M | -2.01M |
| Capital Expenditure | -1.70K | -1.70K | -3.80K | -2.90K | -23.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.70K | -1.70K | -3.80K | -2.90K | -23.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22.50K | -22.50K | -22.50K | -30.00K | -7.50K |
| Issuance of Common Stock | 3.20M | 650.00K | 650.00K | 2.83M | 2.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -258.40K | -38.40K | -40.50K | -209.80K | -209.80K |
| Cash from Financing | 2.09M | 430.30K | 428.70K | 1.93M | 1.95M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 657.40K | -1.22M | -1.39M | -20.20K | -84.20K |
